Neopterin is associated with cardiovascular events and all-cause mortality in renal transplant patients
暂无分享,去创建一个
W. März | I. Holme | S. Pilz | A. Jardine | H. Pihlstrøm | H. Holdaas | G. Mjøen | S. Abedini | Dag Olav Dahle | B. Fellström
[1] G. Sulo,et al. Neopterin and kynurenine-tryptophan ratio as predictors of coronary events in older adults, the Hordaland Health Study. , 2013, International journal of cardiology.
[2] J. Gostner,et al. Redox regulation of the immune response , 2013, Redox report : communications in free radical research.
[3] E. Kaminski,et al. Serum neopterin as an indicator of increased risk of renal allograft rejection. , 2013, Transplant immunology.
[4] A. Gaipov,et al. The Relationship between Oxidative Stress, Inflammation, and Atherosclerosis in Renal Transplant and End-Stage Renal Disease Patients , 2012, Renal failure.
[5] V. Jha,et al. Association between Serum Neopterin and Inflammatory Activation in Chronic Kidney Disease , 2012, Mediators of inflammation.
[6] W. März,et al. Osteoprotegerin as a predictor of renal and cardiovascular outcomes in renal transplant recipients: follow-up data from the ALERT study. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[7] P. Heeger,et al. Transplant immunology for non-immunologist. , 2012, The Mount Sinai journal of medicine, New York.
[8] P. Stenvinkel,et al. Dialysis in 2011: Can cardiovascular risk in dialysis patients be decreased? , 2012, Nature Reviews Nephrology.
[9] M. Nafar,et al. Oxidative stress in kidney transplantation: causes, consequences, and potential treatment. , 2011, Iranian journal of kidney diseases.
[10] W. März,et al. Inflammation-associated graft loss in renal transplant recipients. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[11] A. Jardine,et al. Prevention of cardiovascular disease in adult recipients of kidney transplants , 2011, The Lancet.
[12] T. Mueller,et al. Macrophage activation is associated with poorer long‐term outcomes in renal transplant patients , 2011, Clinical transplantation.
[13] M. Chiariello,et al. Neopterin: from forgotten biomarker to leading actor in cardiovascular pathophysiology. , 2011, Current vascular pharmacology.
[14] D. Fuchs,et al. Inflammation, adiponectin, obesity and cardiovascular risk. , 2010, Current medicinal chemistry.
[15] N. Punjabi,et al. Serum levels of the immune activation marker neopterin change with age and gender and are modified by race, BMI, and percentage of body fat. , 2010, The journals of gerontology. Series A, Biological sciences and medical sciences.
[16] J. Kaski,et al. Neopterin levels and left ventricular dysfunction in patients with chronic stable angina pectoris. , 2009, Atherosclerosis.
[17] D. Fuchs,et al. The role of neopterin in atherogenesis and cardiovascular risk assessment. , 2009, Current medicinal chemistry.
[18] K. Midthjell,et al. Neopterin predicts the risk for fatal ischemic heart disease in type 2 diabetes mellitus: long-term follow-up of the HUNT 1 study. , 2009, Atherosclerosis.
[19] W. März,et al. Inflammation in renal transplantation. , 2009, Clinical journal of the American Society of Nephrology : CJASN.
[20] D. Fuchs,et al. Neopterin as a predictor of total and cardiovascular mortality in individuals undergoing angiography in the Ludwigshafen Risk and Cardiovascular Health study. , 2009, Clinical chemistry.
[21] M. Erdogan,et al. Alterations in l-arginine and inflammatory markers in type 2 diabetic patients with and without microalbuminuria , 2009, Acta Diabetologica.
[22] E. Kaminski,et al. The value of serum neopterin, interferon‐gamma levels and interleukin‐12B polymorphisms in predicting acute renal allograft rejection , 2008, Clinical and experimental immunology.
[23] E. Çakır,et al. Relations between Concentrations of Asymmetric Dimethylarginine and Neopterin as Potential Risk Factors for Cardiovascular Diseases in Haemodialysis-Treated Patients , 2008, Renal failure.
[24] M. Sabatine,et al. Long-Term Prognostic Value of Neopterin: A Novel Marker of Monocyte Activation in Patients With Acute Coronary Syndrome , 2007, Circulation.
[25] S. Takahara,et al. Serum and urinary neopterin as markers in renal transplant patients , 2007, International Urology and Nephrology.
[26] W. Padberg,et al. Post‐Transplant sCD30 and Neopterin as Predictors of Chronic Allograft Nephropathy: Impact of Different Immunosuppressive Regimens , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[27] A. Bakr,et al. Serum neopterin levels in children with primary nephrotic syndrome , 2003, Acta paediatrica.
[28] A. Hartmann,et al. Long‐term Cardiac Outcomes in Renal Transplant Recipients Receiving Fluvastatin: The ALERT Extension Study , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[29] W. Padberg,et al. sCD30 and neopterin as risk factors of chronic renal transplant rejection: impact of cyclosporine A, tacrolimus, and mycophenolate mofetil. , 2005, Transplantation proceedings.
[30] J. Wolf,et al. Neopterin im Serum und Urin zur Differentialdiagnose von Nierenfunktionsstörungen nach Nierentransplantation , 1987, Klinische Wochenschrift.
[31] D. Fuchs,et al. Increasing production of homocysteine and neopterin and degradation of tryptophan with older age. , 2004, Clinical biochemistry.
[32] M. Arias,et al. Proteinuria: a new marker of long-term graft and patient survival in kidney transplantation. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[33] D. Fuchs,et al. Potential role of immune system activation-associated production of neopterin derivatives in humans , 2003, Inflammation Research.
[34] I. Holme,et al. Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial , 2003, The Lancet.
[35] D. Fuchs,et al. Factors influencing serum neopterin concentrations in a population of blood donors. , 2002, Clinical chemistry.
[36] Grebe So,et al. Immune monitoring in organ transplantation using neopterin. , 2002 .
[37] T. Mueller,et al. Immune monitoring in organ transplantation using neopterin. , 2002, Current drug metabolism.
[38] R. Zietse,et al. PROTEINURIA AFTER RENAL TRANSPLANTATION AFFECTS NOT ONLY GRAFT SURVIVAL BUT ALSO PATIENT SURVIVAL , 2001, Transplantation.
[39] I. Holme,et al. Effects of Fluvastatin on Cardiac Events in Renal Transplant Patients: ALERT (Assessment of Lescol® in Renal Transplantation) Study Design and Baseline Data , 2001, Journal of cardiovascular risk.
[40] R. Rodby,et al. Free pentosidine and neopterin as markers of progression rate in diabetic nephropathy , 1998 .
[41] R. Rodby,et al. Free pentosidine and neopterin as markers of progression rate in diabetic nephropathy. Collaborative Study Group. , 1998, Kidney international.
[42] P. Lee,et al. Monitoring of serum neopterin in renal transplant recipients. , 1992, Journal of the Formosan Medical Association = Taiwan yi zhi.
[43] E. Werner,et al. POSTTRANSPLANT NEOPTERIN EXCRETION IN RENAL ALLOGRAFT RECIPIENTS—A RELIABLE DIAGNOSTIC AID FOR ACUTE REJECTION AND A PREDICTIVE MARKER OF LONG‐TERM GRAFT SURVIVAL , 1991, Transplantation.
[44] H. Tilg,et al. In-vitro and in-vivo studies on the induction of neopterin biosynthesis by cytokines, alloantigens and lipopolysaccharide (LPS). , 1988, Clinical and experimental immunology.
[45] H. Tilg,et al. Comparison of serum neopterin levels and urinary neopterin excretion in renal allograft recipients. , 1988, Clinical nephrology.
[46] E. Musch,et al. [Neopterin in the serum and urine in the differential diagnosis of disorders of kidney function following kidney transplantation]. , 1987, Klinische Wochenschrift.
[47] G. Opelz,et al. ASSESSMENT OF PLASMA NEOPTERIN IN CLINICAL KIDNEY TRANSPLANTATION , 1986, Transplantation.
[48] D. Fuchs,et al. Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma , 1984, The Journal of experimental medicine.
[49] D. Fuchs,et al. Neopterin as a new biochemical marker for diagnosis of allograft rejection. Experience based upon evaluation of 100 consecutive cases. , 1983, Transplantation.
[50] G. Brown,et al. THE BIOSYNTHESIS OF FOLIC ACID. IV. ENZYMATIC SYNTHESIS OF DIHYDROFOLIC ACID FROM GUANINE AND RIBOSE COMPOUNDS. , 1964, The Journal of biological chemistry.